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INVITED COMMENTARYCommentary on ‘Uptake of Abdominal Aortic Aneurysm Screening.
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J.J. Earnshaw
Department of Vascular Surgery, Gloucestershire Royal Hospital, Great Western Rd., Gloucester, United KingdomThe Highlands and Islands is one of the sentinel abdom-
inal aortic aneurysm (AAA) screening programmes. Born
of necessity due to the extreme rural nature of the
territory and the high risk that a patient with a ruptured
AAA would not survive the long journey to hospital, it has
provided great beneﬁt to local men for over a decade. It
has become the model for AAA screening in Scotland,
which will be implemented across that country in 2013.
The authors should be congratulated for their results
which show the highest acceptance rates for screening
ever reported (90%). The ﬁnding that their model of
screening delivery accounts for a widely separated
population is reassuring. The fact that deprivation is
associated with lower uptake has also been described in
other (not so rural) populations.
Vascular surgeons have been vociferous in their support
of AAA screening: it is an evidence-based intervention that
reduces premature death from AAA, and of course, for the
surgeon, it avoids the unpleasant, stressful event of dealing
with AAA rupture. However, screening is about choice not
coercion e individuals are invited, not encouraged. The
onus is on screening teams to provide information in such
a way that men decide whether it is in their own best
interests to attend for screening, once invited. It should not
be forgotten that there are risks from AAA screening. About
one man in ten thousand who attends, expecting to be
reassured his aorta is normal, will be found to have a largeDOI of original article: http://dx.doi.org/10.1016/j.ejvs.2013.02.018
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http://dx.doi.org/10.1016/j.ejvs.2013.03.017AAA, and despite best treatment, will have a complication
from which he will not survive. The present furore
surrounding breast cancer screening and possible over-
treatment of non lethal disease must not be allowed to
occur for AAA.
For this reason in the NHS AAA Screening Programme,
and all other UK national programmes, the information
given to men at the time of their invitation has been crafted
carefully, and tested widely, before the programmes
commenced. The invitation includes balanced advice about
both the risks and beneﬁts of attending for AAA screening,
and is available in multiple languages. There is also a new
web-based decision support tool to help men decide
whether or not to accept the offer of screening. It describes
the balance between risk and harm using language and
illustrations that are easy to understand (http://sdm.
rightcare.nhs.uk/pda/aaa-screening/). This resource, and
the information in the national screening invitation leaﬂet,
will be reviewed and updated regularly with the most up to
date evidence and user advice.
Maximising attendance for screening will maximise its
beneﬁt. Therefore ﬁnding ways to penetrate rural and
deprived communities with information in multiple, easy to
understand formats will increase attendance, without
coercion. The biggest single hurdle is the relative ignorance
of the general public about what an AAA is, and the harm it
can cause.
